These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33682851)

  • 1. Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia.
    Landerer H; Arnone M; Wieboldt R; Goersch E; Stanger AMP; Konantz M; Lengerke C
    J Vis Exp; 2021 Feb; (168):. PubMed ID: 33682851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion.
    Paczulla AM; Rothfelder K; Raffel S; Konantz M; Steinbacher J; Wang H; Tandler C; Mbarga M; Schaefer T; Falcone M; Nievergall E; Dörfel D; Hanns P; Passweg JR; Lutz C; Schwaller J; Zeiser R; Blazar BR; Caligiuri MA; Dirnhofer S; Lundberg P; Kanz L; Quintanilla-Martinez L; Steinle A; Trumpp A; Salih HR; Lengerke C
    Nature; 2019 Aug; 572(7768):254-259. PubMed ID: 31316209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia.
    Baragaño Raneros A; Martín-Palanco V; Fernandez AF; Rodriguez RM; Fraga MF; Lopez-Larrea C; Suarez-Alvarez B
    Genes Immun; 2015; 16(1):71-82. PubMed ID: 25393931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease.
    Stojanovic A; Correia MP; Cerwenka A
    Front Immunol; 2018; 9():827. PubMed ID: 29740438
    [TBL] [Abstract]